EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

IV Thrombolysis for Acute Ischemic Stroke with Unknown Onset in Patients on Oral Anticoagulation

Kosmas Macha, Jochen A Sembill, Iris Muehlen, Tobias Engelhorn, Arnd Doerfler, Stefan Schwab, Bernd Kallmünzer

Cerebrovascular Diseases · 2024

DOI: 10.1159/000540552 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cerebrovascular Diseases, 2024. Verfasst von Kosmas Macha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany. Hauptthemen laut MEDLINE: Anticoagulants, Fibrinolytic Agents, Ischemic Stroke, Thrombolytic Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

IV thrombolysis (IVT) is established in the unknown or extended time window based on multimodal imaging. Further, increasing evidence exists regarding IVT in patients on oral anticoagulation including direct oral anticoagulants (DOACs). However, data on IVT in ischemic stroke patients on oral anticoagulation with unknown time of stroke onset are sparse.

Methods

This study bases on the longitudinal cohort study Stroke Research Consortium in Northern Bavaria (STAMINA; ClinicalTrials.gov Identifier: NCT04357899). Acute ischemic stroke patients treated with IVT in the unknown or extended time window from January 2015 to December 2019 were included. Patient selection was based on multimodal CT or MRI. Patients on oral anticoagulation (vitamin-K antagonist [VKA] or DOAC within 48 h) were eligible for IVT based on INR measurement (VKA) or plasma levels (DOAC) according to an institutional protocol. Primary outcomes were the incidence of any and symptomatic intracranial hemorrhage.

Results

Of 170 ischemic stroke patients treated with IVT in the unknown or extended time window, 151 had no oral anticoagulation at stroke onset and 19 were on oral anticoagulation (6 on VKA and 13 on DOAC). The risk of symptomatic ICH according to ECASS II criteria was similar between the patients with and without oral anticoagulation (1 [5.3%] vs. 4 [2.7%], p = 0.453). After adjustment for confounding factors, pre-medication with oral anticoagulation was not associated with symptomatic ICH (aOR 1.02 [0.09–11.02], p = 0.988).

Conclusion

IVT for ischemic stroke with unknown onset appeared safe in selected patients on oral anticoagulation with both DOAC and VKA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsFibrinolytic AgentsIschemic StrokeThrombolytic TherapyTime-to-TreatmentAgedAged, 80 and overFemaleHumansMaleMiddle AgedAdministration, OralGermanyIntracranial HemorrhagesLongitudinal StudiesRisk AssessmentRisk FactorsTime FactorsTreatment Outcome

Stichwörter der Autor:innen

Direct oral anticoagulantIV thrombolysisIschemic strokeUnknown onsetVitamin-K antagonist

Substanzen

AnticoagulantsFibrinolytic Agents

Autor:innen und Institutionen

  • Department of Neurology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Department of Neuroradiology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Zitieren

APA

Macha, K., Sembill, J. A., Muehlen, I., Engelhorn, T., Doerfler, A., Schwab, S., & Kallmünzer, B. (2024). IV Thrombolysis for Acute Ischemic Stroke with Unknown Onset in Patients on Oral Anticoagulation. Cerebrovascular Diseases. https://doi.org/10.1159/000540552

Vancouver

Macha K, Sembill JA, Muehlen I, Engelhorn T, Doerfler A, Schwab S, et al. IV Thrombolysis for Acute Ischemic Stroke with Unknown Onset in Patients on Oral Anticoagulation. Cerebrovascular Diseases. 2024. doi:10.1159/000540552

BibTeX
@article{Macha2024,
  author = {Macha, Kosmas and Sembill, Jochen A and Muehlen, Iris and Engelhorn, Tobias and Doerfler, Arnd and Schwab, Stefan and Kallmünzer, Bernd},
  title = {IV Thrombolysis for Acute Ischemic Stroke with Unknown Onset in Patients on Oral Anticoagulation},
  journal = {Cerebrovascular Diseases},
  year = {2024},
  doi = {10.1159/000540552}
}
Kostenlos starten →